The polynucleotides injectable market is poised for remarkable growth, driven by increasing aesthetic awareness among consumers globally. The demand for non-surgical options is growing at an impressive pace, projected to achieve a market size of USD 17.5 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.13% from USD 10.09 billion in 2024. This trajectory underscores a...